CStone Pharmaceuticals

HK$5.34As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2616Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 8Y CAGR (10.36%)
Div yield —
ROE (52.14%)
Biotechnology
Beta (5Y) 0.29
PE TTM —
TSR TTM (14.62%)
Mkt cap HK$8.507B
ROIC (19.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.29
(1.02%)
(91.93%)
Hold 8|9|5|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.07
0.07
0.08
17.11%
33.03%
24.99%
16.16%
Revenue¥M
537.4
544.4
551.6
583.3
(0.34%)
(0.02%)
2.43%
8.40%
Peers (US$1.085B)
Cap (US$)
PE
1.093B
12.92x
1.086B
26.50x
Capital
TTM
5Y
10Y
Leveragex
0.203
0.264
0.208
EBIT/Intx
6.107
0.350
0.326
Own earn%
0.34
(4.48)
(20.20)
Sh yield%
35.19
20.71
21.41
Owners
Insiders/Inst%
1.03
81.52
Short interest%
1.96
SBC / revenue%
0.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
0–12
$1 testx
0.3
Incr. ROIC%
3